Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by dt_coreon Mar 10, 2011 1:55pm
179 Views
Post# 18266744

Market Depth

Market DepthCan someone please post updated Market Depth? Thanks in advance.

The PM from Front Street was on BNN last night talking about HEM. Despite the fact they have been selling for the past year or so and now hold only ~800K shs he said they were cautiously optimistic on the name. In his words "it's a great small cap stock".

As well, J. Huang was ony about 1.5 weeks ago with a strong buy on HEM.

Overall, nice to see some of the buy-side institutional shops are buying shares and see the value in the company.

Still can't believe I managed to pick up that block yesterday. Honestly didn't think with the positive business momentum of HEM that I would get an opportunity like that. Regardless of the volatility I'm quite pleased with the outlook. IMO could easily be a 3x to 4x return from current levels. I think this will be one of the last great buying opportunities on the name for some time to come (although its clear some trader or program is playing silly buggers with the share price). To those that like the story now's a good time to get in on the cheap.
Bullboard Posts